I recently had the privilege of being the opening keynote speaker at the Financial Times Camp Alphaville 2015 conference in London. Attending were nearly 1000 people, including economists, engineers, scientists, and financiers. Amongst robots mingling with guests, panels discussing Greece’s future, and Andrew Fastow describing the fall of Enron in his closing speech, event participants were given a dynamic picture of the ever changing business landscape and its effect on our lives.
One thing I noticed at the conference was the increasing interest in longevity science–the transhumanist field that aims to control and hopefully even eliminate aging in the near future. Naturally, everyone has a vested interest in some type of control over their aging and biological mortality. We are, at the core, mammals primarily interested in our health, the health of our loved ones, and the health of our species. But the feeling at the conference–and in the media these days too–was more pronounced than before.
With billionaires like Peter Thiel and Larry Ellison openly putting money into aging research, and behemoths like Google recently forming its anti-aging company Calico, there’s real confidence that the human race may end up stopping death in the next few decades. There’s also growing confidence that companies can make fortunes in the immortality quest.
Google Ventures’ President Bill Maris, who helps direct investments into health and science companies, recently made headlines by telling Bloomberg, “If you ask me today, is it possible to live to be 500? The answer is yes.”